IL17RB and plasma cell myeloma: As impaired CRBN-CRL4 E3 ligase activity due to mutation, deletion or downregulation leads to altered IMiD-sensitivity in multiple myeloma cell lines and patients9–11, we examined its status in the five patients included in our proteomic analyses.